SWA
IDXX icon

Stratos Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

Stratos Wealth Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,755
Closed -$1.22M – 572
2022
Q3 		$1.22M Buy
3,755
+199
+6% +$73.1K 0.13% 217
2022
Q2 		$1.25M Buy
3,556
+704
+25% +$287K 0.11% 228
2022
Q1 		$1.56M Buy
2,852
+547
+24% +$288K 0.13% 200
2021
Q4 		$1.52M Buy
2,305
+269
+13% +$169K 0.11% 222
2021
Q3 		$1.27M Sell
2,036
-63
-3% -$42.3K 0.11% 225
2021
Q2 		$1.33M Buy
+2,099
New +$1.16M 0.12% 200

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Stratos Wealth Advisors's IDXX Position: Q4 2022 in Review

Stratos Wealth Advisors sold out of Idexx Laboratories (IDXX) in Q4 2022, closing a stake of 3,755 shares — an estimated $1.22M sold.

Stratos Wealth Advisors first reported a position in IDXX in Q2 2021 and held it in 6 quarters. The position peaked at $1.56M in Q1 2022. 999 funds tracked by Wall St. Rank hold IDXX as of Q4 2022.

  • Stratos Wealth Advisors reported no remaining Idexx Laboratories position as of Q4 2022 after selling out during the quarter.
  • Stratos Wealth Advisors sold 3,755 Idexx Laboratories shares in Q4 2022, an estimated $1.22M.
  • Stratos Wealth Advisors first reported a position in Idexx Laboratories in Q2 2021 and held it in 6 quarters.
  • Stratos Wealth Advisors's Idexx Laboratories position peaked at $1.56M in Q1 2022.
  • 999 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2022.

Based on Stratos Wealth Advisors's 13F filing for Q4 2022, filed 19 Jan 2023.